The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukemia, Lymphocytic, Chronic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukemia, Lymphocytic, Chronic


High impact information on Leukemia, Lymphocytic, Chronic


Chemical compound and disease context of Leukemia, Lymphocytic, Chronic


Biological context of Leukemia, Lymphocytic, Chronic


Anatomical context of Leukemia, Lymphocytic, Chronic


Gene context of Leukemia, Lymphocytic, Chronic


Analytical, diagnostic and therapeutic context of Leukemia, Lymphocytic, Chronic


  1. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. Piro, L.D., Carrera, C.J., Carson, D.A., Beutler, E. N. Engl. J. Med. (1990) [Pubmed]
  2. Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine. Trendle, M.C., Tefferi, A. N. Engl. J. Med. (1994) [Pubmed]
  3. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. Kato, K., Cantwell, M.J., Sharma, S., Kipps, T.J. J. Clin. Invest. (1998) [Pubmed]
  4. Detection and partial characterization of human thymus-leukemia antigens. Dowell, B.L., Falletta, J.M., Moore, J.O., Metzgar, R.S. J. Natl. Cancer Inst. (1980) [Pubmed]
  5. Analysis of RAS oncogene mutations in human lymphoid malignancies. Neri, A., Knowles, D.M., Greco, A., McCormick, F., Dalla-Favera, R. Proc. Natl. Acad. Sci. U.S.A. (1988) [Pubmed]
  6. Fludarabine for chronic lymphocytic leukemia. Proctor, S.J., Mounter, P., Summerfield, G.P. N. Engl. J. Med. (2001) [Pubmed]
  7. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. Rai, K.R., Peterson, B.L., Appelbaum, F.R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G.A., Larson, R.A., Cheson, B.D., Schiffer, C.A. N. Engl. J. Med. (2000) [Pubmed]
  8. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. Juliusson, G., Elmhorn-Rosenborg, A., Liliemark, J. N. Engl. J. Med. (1992) [Pubmed]
  9. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Cantwell, M., Hua, T., Pappas, J., Kipps, T.J. Nat. Med. (1997) [Pubmed]
  10. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia. Saven, A., Piro, L. N. Engl. J. Med. (1994) [Pubmed]
  11. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. Dighiero, G., Maloum, K., Desablens, B., Cazin, B., Navarro, M., Leblay, R., Leporrier, M., Jaubert, J., Lepeu, G., Dreyfus, B., Binet, J.L., Travade, P. N. Engl. J. Med. (1998) [Pubmed]
  12. Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer. Ho, A.D., Thaler, J., Stryckmans, P., Coiffier, B., Luciani, M., Sonneveld, P., Lechner, K., Rodenhuis, S., Peetermans, M.E., deCataldo, F. J. Natl. Cancer Inst. (1990) [Pubmed]
  13. Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. Geleziunas, R., McQuillan, A., Malapetsa, A., Hutchinson, M., Kopriva, D., Wainberg, M.A., Hiscott, J., Bramson, J., Panasci, L. J. Natl. Cancer Inst. (1991) [Pubmed]
  14. Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia. Johnston, J.B., Israels, L.G., Goldenberg, G.J., Anhalt, C.D., Verburg, L., Mowat, M.R., Begleiter, A. J. Natl. Cancer Inst. (1990) [Pubmed]
  15. 2-Chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancies. Saven, A., Piro, L.D. Ann. Intern. Med. (1994) [Pubmed]
  16. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. Chu, P., Deforce, D., Pedersen, I.M., Kim, Y., Kitada, S., Reed, J.C., Kipps, T.J. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  17. Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes. Walker, A.M., Montgomery, D.W., Saraiya, S., Ho, T.W., Garewal, H.S., Wilson, J., Lorand, L. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  18. Chromosome abnormalities and RB1 gene deletions in chronic lymphocytic leukemia. Juliusson, G., Gahrton, G., Einhorn, S., Liu, Y., Oscier, D.G., Chapman, R. Blood (1993) [Pubmed]
  19. Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations. Mackey, J.R., Galmarini, C.M., Graham, K.A., Joy, A.A., Delmer, A., Dabbagh, L., Glubrecht, D., Jewell, L.D., Lai, R., Lang, T., Hanson, J., Young, J.D., Merle-Béral, H., Binet, J.L., Cass, C.E., Dumontet, C. Blood (2005) [Pubmed]
  20. Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia. Mendelsohn, J., Nordberg, J. J. Clin. Invest. (1979) [Pubmed]
  21. Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. Tung, R., Silber, R., Quagliata, F., Conklyn, M., Gottesman, J., Hirschhorn, R. J. Clin. Invest. (1976) [Pubmed]
  22. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation. Cohen, J.H., Revillard, J.P., Magaud, J.P., Lenoir, G., Vuillaume, M., Manel, A.M., Vincent, C., Bryon, P.A. J. Natl. Cancer Inst. (1987) [Pubmed]
  23. Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes. Logue, G.L., Cohen, H.J. J. Clin. Invest. (1977) [Pubmed]
  24. Isolation and partial characterization of Fc gamma-binding proteins of human leukocytes. Kulczycki, A., Solanki, L., Cohen, L. J. Clin. Invest. (1981) [Pubmed]
  25. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Trentin, L., Zambello, R., Agostini, C., Enthammer, C., Cerutti, A., Adami, F., Zamboni, S., Semenzato, G. Blood (1994) [Pubmed]
  26. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Lin, K., Sherrington, P.D., Dennis, M., Matrai, Z., Cawley, J.C., Pettitt, A.R. Blood (2002) [Pubmed]
  27. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Kröber, A., Seiler, T., Benner, A., Bullinger, L., Brückle, E., Lichter, P., Döhner, H., Stilgenbauer, S. Blood (2002) [Pubmed]
  28. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Lee, Y.K., Bone, N.D., Strege, A.K., Shanafelt, T.D., Jelinek, D.F., Kay, N.E. Blood (2004) [Pubmed]
  29. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells. van Kooten, C., Rensink, I., Aarden, L., van Oers, R. Blood (1992) [Pubmed]
  30. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. Scielzo, C., Ghia, P., Conti, A., Bachi, A., Guida, G., Geuna, M., Alessio, M., Caligaris-Cappio, F. J. Clin. Invest. (2005) [Pubmed]
  31. Lymphocyte plasma membranes. VI. Surface antigens of lymphocytes in chronic lymphocytic leukemia. Zimmerman, B., Chapman, M.L. J. Natl. Cancer Inst. (1976) [Pubmed]
  32. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Anaissie, E.J., Kontoyiannis, D.P., O'Brien, S., Kantarjian, H., Robertson, L., Lerner, S., Keating, M.J. Ann. Intern. Med. (1998) [Pubmed]
  33. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Gribben, J.G., Zahrieh, D., Stephans, K., Bartlett-Pandite, L., Alyea, E.P., Fisher, D.C., Freedman, A.S., Mauch, P., Schlossman, R., Sequist, L.V., Soiffer, R.J., Marshall, B., Neuberg, D., Ritz, J., Nadler, L.M. Blood (2005) [Pubmed]
WikiGenes - Universities